Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2353${count})

  • Research Grant, 2021
    Parkinson’s Disease Patient Report of Problems (PD-PROP) Curation

    Study Rationale:
    What people with Parkinson’s feel and experience about their disease, and how it affects their lives, is of paramount importance to their care and participation in research. The...

  • Priority Biology, 2021
    Studying the Properties of Alpha-Synuclein Aggregates Amplified from Human Cerebrospinal Fluid

    Study Rationale:
    Aggregates of the protein alpha-synuclein, which accumulate in the brains of people with Parkinson’s disease (PD), can also be detected in biofluids like cerebrospinal fluid (CSF)...

  • Research Grant, 2021
    Hypoxia (Limiting Oxygen Levels) as a Novel Treatment for Parkinson’s Disease

    Study Rationale:
    Many anecdotes suggest that people with Parkinson’s disease (PD) can experience a marked improvement in symptoms when they travel to the mountains or during flights at high altitude...

  • Biosample Use Program, 2021
    Evaluating Neurotoxic Metabolites as Biomarkers of Parkinson’s Progression

    Study Rationale:    
    Individuals with Parkinson’s disease (PD) show elevated markers of inflammation in their brains, cerebrospinal fluid and blood. We think that inflammation drives the worsening of...

  • Target Advancement Program, 2021
    SCARB2 as a Potential Target in Parkinson’s Disease

    Study Rationale:
    Mutations in GBA, a gene that encodes an enzyme called glucocerebrosidase, are a common risk factor for Parkinson’s disease (PD). Inside cells, glucocerebrosidase must be escorted to...

  • Target Advancement Program, 2021
    Targeting the Chemical Modification of DNA to Suppress Neurodegeneration in Parkinson’s Disease

    Study Rationale:     
    Genes can be switched on or off by proteins that add and remove chemical modifications to DNA. We and others have shown that the chemical modification of genes important for...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.